Cargando…
Regulatory T cells and M2 macrophages present diverse prognostic value in gastric cancer patients with different clinicopathologic characteristics and chemotherapy strategies
BACKGROUND: Gastric cancer (GC) remains a refractory cancer worldwide. Currently, exploring the differences of the immune status in GC patients with different subgroups might provide promising immunotherapeutic approaches for the treatment of GC. METHODS: In this study, a total of 598 surgically res...
Autores principales: | Liu, Xu, Xu, Danhua, Huang, Chen, Guo, Yixian, Wang, Shuchang, Zhu, Chunchao, Xu, Jia, Zhang, Zizhen, Shen, Yanying, Zhao, Wenyi, Zhao, Gang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6554965/ https://www.ncbi.nlm.nih.gov/pubmed/31174544 http://dx.doi.org/10.1186/s12967-019-1929-9 |
Ejemplares similares
-
Role of LATS1/2 in Prognosis of Advanced Gastric Cancer and Its Relationship With the Tumor Immune Microenvironment
por: Guo, Yixian, et al.
Publicado: (2020) -
Somatic mutation of DNAH genes implicated higher chemotherapy response rate in gastric adenocarcinoma patients
por: Zhu, Chunchao, et al.
Publicado: (2019) -
CCL19/CCR7 drives regulatory T cell migration and indicates poor prognosis in gastric cancer
por: Xu, Danhua, et al.
Publicado: (2023) -
High-level of intratumoral GITR+ CD4 T cells associate with poor prognosis in gastric cancer
por: Ke, Shouyu, et al.
Publicado: (2022) -
Long Non-Coding RNA NRON promotes Tumor Proliferation by regulating ALKBH5 and Nanog in Gastric Cancer
por: Wang, Shuchang, et al.
Publicado: (2021)